Sheila Assunção, José Jiménez, Nora Pacheco, Fabiola Navarro Marún, Douglas Quintero, Isabel Aspilcueta Flores, Carlos L Pérez Desanti, Arsenio Rosado-Franco, Guillermo Tapia Paniagua, Amado Nieto Caraveo, Sergio Sanchez Cázares, Jaime Aguilar Gasca, Erick Landa Fournais, Joanna Leadbetter
OBJECTIVE: To compare the effectiveness of a 12 months antipsychotic monotherapy treatment with Olanzapine, risperidone and an atypical antipsychotic drug in Latin American patients with schizophrenia. METHOD: The outcomes of effectiveness and tolerability were evaluated in outpatients with schizophrenia belonging to a large sample (N=7658) in a prospective, international trial carried out in 27 countries. The results for the population of Latin America were presented...
July 2005: Vertex: Revista Argentina de Psiquiatriá